Evidence map›Paper›PMID 25770819›Full record

ArticleEMBO molecular medicine2015

Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response.

James K Chan, Graeme E Glass, Adel Ersek, Andrew Freidin, Garry A Williams, Kate Gowers, Ana I Espirito Santo, Rosemary Jeffery, William R Otto, Richard Poulsom and 4 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Review
  3. Biologic immunomodulators and spinal fusion: evidence, mechanisms, and perioperative considerations.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Article
  15. The local and systemic effects of immune function on fracture healing.OTA international : the open access journal of orthopaedic trauma · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

James K ChanKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Graeme E GlassKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Adel ErsekKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Andrew FreidinKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Garry A WilliamsKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Kate GowersNational Heart and Lung Institute, Imperial College London, London, UK.
Ana I Espirito SantoKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Rosemary JefferyHistopathology Laboratory and In Situ Hybridisation Service, Cancer Research UK - London Research Institute, London, UK.
William R OttoHistopathology Laboratory and In Situ Hybridisation Service, Cancer Research UK - London Research Institute, London, UK.
Richard PoulsomHistopathology Laboratory and In Situ Hybridisation Service, Cancer Research UK - London Research Institute, London, UK.
Marc FeldmannKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Sara M RankinNational Heart and Lung Institute, Imperial College London, London, UK.
Nicole J HorwoodKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Jagdeep NanchahalKennedy Institute of Rheumatology, University of Oxford, Oxford, UK jagdeep.nanchahal@kennedy.ox.ac.uk.
University of Oxford · GBCancer Research UK · GBImperial College London · GB

Funding

Medical Research Council G0900160Medical Research Council MR/K007939/1Wellcome TrustWellcome Trust WT096035MA
6 · The paper itself

Abstract

The mechanism by which trauma initiates healing remains unclear. Precise understanding of these events may define interventions for accelerating healing that could be translated to the clinical arena. We previously reported that addition of low-dose recombinant human TNF (rhTNF) at the fracture site augmented fracture repair in a murine tibial fracture model. Here, we show that local rhTNF treatment is only effective when administered within 24 h of injury, when neutrophils are the major inflammatory cell infiltrate. Systemic administration of anti-TNF impaired fracture healing. Addition of rhTNF enhanced neutrophil recruitment and promoted recruitment of monocytes through CCL2 production. Conversely, depletion of neutrophils or inhibition of the chemokine receptor CCR2 resulted in significantly impaired fracture healing. Fragility, or osteoporotic, fractures represent a major medical problem as they are associated with permanent disability and premature death. Using a murine model of fragility fractures, we found that local rhTNF treatment improved fracture healing during the early phase of repair. If translated clinically, this promotion of fracture healing would reduce the morbidity and mortality associated with delayed patient mobilization.

Indexed as

AnimalsBone and BonesChemokine CCL2Disease Models, AnimalFracture HealingFractures, BoneHumansImmunity, InnateMiceMonocytesNeutrophilsRecombinant ProteinsTumor Necrosis Factor-alphaCcl2 protein, mouseChemokine CCL2Recombinant ProteinsTumor Necrosis Factor-alphaboneCCL2fractureinflammationTNF

Identifiers

PMID25770819
PMCPMC4492816
OpenAlexW2138810805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.